158 related articles for article (PubMed ID: 36786157)
1. Shape programmable
Liu M; Yuan J; Wang G; Ni N; Lv Q; Liu S; Gong Y; Zhao X; Wang X; Sun X
Nanoscale; 2023 Mar; 15(10):4694-4724. PubMed ID: 36786157
[TBL] [Abstract][Full Text] [Related]
2. Magnetic targeting combined with active targeting of dual-ligand iron oxide nanoprobes to promote the penetration depth in tumors for effective magnetic resonance imaging and hyperthermia.
Chen L; Wu Y; Wu H; Li J; Xie J; Zang F; Ma M; Gu N; Zhang Y
Acta Biomater; 2019 Sep; 96():491-504. PubMed ID: 31302299
[TBL] [Abstract][Full Text] [Related]
3. Water-Nanomaterial Interaction to Escalate Twin-Mode Magnetic Resonance Imaging.
Haribabu V; Girigoswami K; Sharmiladevi P; Girigoswami A
ACS Biomater Sci Eng; 2020 Aug; 6(8):4377-4389. PubMed ID: 33455176
[TBL] [Abstract][Full Text] [Related]
4. Advances of Light/Ultrasound/Magnetic-Responsive Nanoprobes for Visualized Theranostics of Urinary Tumors.
Yang F; Li S; Jiao M; Wu D; Wang L; Cui Z; Zeng L
ACS Appl Bio Mater; 2022 Feb; 5(2):438-450. PubMed ID: 35043619
[TBL] [Abstract][Full Text] [Related]
5. PDGFB-targeted functional MRI nanoswitch for activatable T
Zhang Y; Liu L; Li W; Zhang C; Song T; Wang P; Sun D; Huang X; Qin X; Ran L; Tian G; Qian J; Zhang G
J Nanobiotechnology; 2023 Jan; 21(1):9. PubMed ID: 36609374
[TBL] [Abstract][Full Text] [Related]
6. A pH-Responsive Yolk-Like Nanoplatform for Tumor Targeted Dual-Mode Magnetic Resonance Imaging and Chemotherapy.
Sun X; Du R; Zhang L; Zhang G; Zheng X; Qian J; Tian X; Zhou J; He J; Wang Y; Wu Y; Zhong K; Cai D; Zou D; Wu Z
ACS Nano; 2017 Jul; 11(7):7049-7059. PubMed ID: 28665575
[TBL] [Abstract][Full Text] [Related]
7. Shield-activated two-way imaging nanomaterials for enhanced cancer theranostics.
Xu Y; Nie Z; Ni N; Zhang X; Yuan J; Gao Y; Gong Y; Liu S; Wu M; Sun X
Biomater Sci; 2022 Dec; 10(24):6893-6910. PubMed ID: 36317535
[TBL] [Abstract][Full Text] [Related]
8. Self-Confirming Magnetosomes for Tumor-Targeted T
Jiang G; Fan D; Tian J; Xiang Z; Fang Q
Adv Healthc Mater; 2022 Jul; 11(14):e2200841. PubMed ID: 35579102
[TBL] [Abstract][Full Text] [Related]
9. Dual T
Suárez-García S; Arias-Ramos N; Frias C; Candiota AP; Arús C; Lorenzo J; Ruiz-Molina D; Novio F
ACS Appl Mater Interfaces; 2018 Nov; 10(45):38819-38832. PubMed ID: 30351897
[TBL] [Abstract][Full Text] [Related]
10.
Li Y; Cui J; Li C; Zhou H; Chang J; Aras O; An F
ChemMedChem; 2022 Feb; 17(4):e202100701. PubMed ID: 34951121
[TBL] [Abstract][Full Text] [Related]
11. Surface Design of Eu-Doped Iron Oxide Nanoparticles for Tuning the Magnetic Relaxivity.
Park JC; Lee GT; Kim HK; Sung B; Lee Y; Kim M; Chang Y; Seo JH
ACS Appl Mater Interfaces; 2018 Aug; 10(30):25080-25089. PubMed ID: 29989402
[TBL] [Abstract][Full Text] [Related]
12. Engineering Persistent Luminescence Nanoparticles for Biological Applications: From Biosensing/Bioimaging to Theranostics.
Sun SK; Wang HF; Yan XP
Acc Chem Res; 2018 May; 51(5):1131-1143. PubMed ID: 29664602
[TBL] [Abstract][Full Text] [Related]
13. Tumor-penetrating iron oxide nanoclusters for
Li J; Gong S; Li S; Li X; Lan S; Sun M
Biomater Sci; 2022 Sep; 10(18):5254-5264. PubMed ID: 35913090
[TBL] [Abstract][Full Text] [Related]
14. Recent Progress in 808 nm Excited Upconversion Nanomaterials as Multifunctional Nanoprobes for Visualized Theranostics in Cancers.
Zeng L; Wu D; Tian Y; Pan Y; Wu A; Zhang J; Lu G
Curr Med Chem; 2018; 25(25):2954-2969. PubMed ID: 28322153
[TBL] [Abstract][Full Text] [Related]
15. T
Li J; You J; Wu C; Dai Y; Shi M; Dong L; Xu K
Int J Nanomedicine; 2018; 13():4607-4625. PubMed ID: 30127609
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of Ferromagnetic Fe0.6 Mn0.4 O Nanoflowers as a New Class of Magnetic Theranostic Platform for In Vivo T1 -T2 Dual-Mode Magnetic Resonance Imaging and Magnetic Hyperthermia Therapy.
Liu XL; Ng CT; Chandrasekharan P; Yang HT; Zhao LY; Peng E; Lv YB; Xiao W; Fang J; Yi JB; Zhang H; Chuang KH; Bay BH; Ding J; Fan HM
Adv Healthc Mater; 2016 Aug; 5(16):2092-104. PubMed ID: 27297640
[TBL] [Abstract][Full Text] [Related]
17. 2D Nanomaterials for Cancer Theranostic Applications.
Cheng L; Wang X; Gong F; Liu T; Liu Z
Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752
[TBL] [Abstract][Full Text] [Related]
18. MRI-traceable theranostic nanoparticles for targeted cancer treatment.
Anani T; Rahmati S; Sultana N; David AE
Theranostics; 2021; 11(2):579-601. PubMed ID: 33391494
[TBL] [Abstract][Full Text] [Related]
19. Single-Atom Gd Nanoprobes for Self-Confirmative MRI with Robust Stability.
Luo Q; Liu J; Ma Q; Xu S; Wang L
Small; 2023 Jun; 19(23):e2206821. PubMed ID: 36919250
[TBL] [Abstract][Full Text] [Related]
20. pH-responsive iron manganese silicate nanoparticles as T1-T2* dual-modal imaging probes for tumor diagnosis.
Chen J; Zhang WJ; Guo Z; Wang HB; Wang DD; Zhou JJ; Chen QW
ACS Appl Mater Interfaces; 2015 Mar; 7(9):5373-83. PubMed ID: 25685956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
